SIRT2 and non-small cell lung carcinoma: SIRT2 overexpression in NSCLC enhanced the expression level of p27, a cell cycle protein dependent kinase inhibitor, and hindered the proliferation of NSCLC cells by promoting the deacetylation and degradation of S-phase kinase-associated protein 2 (Skp2).